Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Rowe

Showing results (171-180 of 269) with videos related to

Pageof 27
Sort By:
American Journal of Respiratory Cell and Molecular Biology|May 7, 2020
Novel Therapy of Bicarbonate, Glutathione, and Ascorbic Acid Improves Cystic Fibrosis Mucus TransportAdegboyega Timothy Adewale, Emily Falk Libby, Lianwu Fu, et al.
Molecular Therapy. Methods & Clinical Development|July 25, 2018
An Adeno-Associated Viral Vector Capable of Penetrating the Mucus Barrier to Inhaled Gene TherapyGregg A Duncan, Namho Kim, Yanerys Colon-Cortes, et al.
Frontiers in Medicine|February 11, 2020
The Effects of the Anti-aging Protein Klotho on Mucociliary ClearanceJaleesa Garth, Molly Easter, Elex Skylar Harris, et al.
Journal of Ginseng Research|January 13, 2021
Korean Red Ginseng aqueous extract improves markers of mucociliary clearance by stimulating chloride secretionDo-Yeon Cho, Daniel Skinner, Shaoyan Zhang, et al.
American Journal of Respiratory and Critical Care Medicine|September 24, 2024
Ivacaftor for Chronic Obstructive Pulmonary Disease - Results from a Phase 2, Randomized Controlled TrialKadambari Vijaykumar, George M Solomon, Jennifer Guimbellot, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 4, 2021
Effect of lumacaftor-ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis: Results from the PROSPECT MCC sub-studyScott H Donaldson, Beth L Laube, Peter Mogayzel, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 22, 2023
Mucociliary clearance augmenting drugs block SARS-CoV-2 replication in human airway epithelial cellsJavier Campos-Gómez, Courtney Fernandez Petty, Marina Mazur, et al.
American Journal of Respiratory and Critical Care Medicine|March 1, 2023
<i>De Novo</i> Generation of Pulmonary Ionocytes from Normal and Cystic Fibrosis Human Induced Pluripotent Stem CellsRuobing Wang, Chantelle Simone-Roach, Jonathan Lindstrom-Vautrin, et al.
International Forum of Allergy & Rhinology|December 11, 2023
Hypoxia-induced cystic fibrosis transmembrane conductance regulator dysfunction is a universal mechanism underlying reduced mucociliary transport in sinusitisDo-Yeon Cho, Shaoyan Zhang, T Graham Norwood, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 14, 2024
The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC StudyScott H Donaldson, Timothy E Corcoran, Joseph M Pilewski, et al.
Pageof 27

Showing results (171-180 of 269) with videos related to

Sort By:
Pageof 27
American Journal of Respiratory Cell and Molecular Biology|May 7, 2020
Novel Therapy of Bicarbonate, Glutathione, and Ascorbic Acid Improves Cystic Fibrosis Mucus TransportAdegboyega Timothy Adewale, Emily Falk Libby, Lianwu Fu, et al.
Molecular Therapy. Methods & Clinical Development|July 25, 2018
An Adeno-Associated Viral Vector Capable of Penetrating the Mucus Barrier to Inhaled Gene TherapyGregg A Duncan, Namho Kim, Yanerys Colon-Cortes, et al.
Frontiers in Medicine|February 11, 2020
The Effects of the Anti-aging Protein Klotho on Mucociliary ClearanceJaleesa Garth, Molly Easter, Elex Skylar Harris, et al.
Journal of Ginseng Research|January 13, 2021
Korean Red Ginseng aqueous extract improves markers of mucociliary clearance by stimulating chloride secretionDo-Yeon Cho, Daniel Skinner, Shaoyan Zhang, et al.
American Journal of Respiratory and Critical Care Medicine|September 24, 2024
Ivacaftor for Chronic Obstructive Pulmonary Disease - Results from a Phase 2, Randomized Controlled TrialKadambari Vijaykumar, George M Solomon, Jennifer Guimbellot, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 4, 2021
Effect of lumacaftor-ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis: Results from the PROSPECT MCC sub-studyScott H Donaldson, Beth L Laube, Peter Mogayzel, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 22, 2023
Mucociliary clearance augmenting drugs block SARS-CoV-2 replication in human airway epithelial cellsJavier Campos-Gómez, Courtney Fernandez Petty, Marina Mazur, et al.
American Journal of Respiratory and Critical Care Medicine|March 1, 2023
<i>De Novo</i> Generation of Pulmonary Ionocytes from Normal and Cystic Fibrosis Human Induced Pluripotent Stem CellsRuobing Wang, Chantelle Simone-Roach, Jonathan Lindstrom-Vautrin, et al.
International Forum of Allergy & Rhinology|December 11, 2023
Hypoxia-induced cystic fibrosis transmembrane conductance regulator dysfunction is a universal mechanism underlying reduced mucociliary transport in sinusitisDo-Yeon Cho, Shaoyan Zhang, T Graham Norwood, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 14, 2024
The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC StudyScott H Donaldson, Timothy E Corcoran, Joseph M Pilewski, et al.
Pageof 27